The glycoproteins of all filovirus species use the same host factors for entry into bat and human cells but entry efficiency is species dependent

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Hoffmann, Markus ^a   Hernández, Mariana González ^a   Berger, Elisabeth ^a   Marzi, Andrea ^b   Pöhlmann, Stefan ^a  

^a GERMAN PRIMATE CENTER   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; GLYCOPROTEIN; MEMBRANE PROTEIN; NIEMANN PICK C1; UNCLASSIFIED DRUG; CARRIER PROTEIN; FURIN; FURIN PROTEIN, HUMAN; NPC1 PROTEIN, HUMAN; VIRAL PROTEIN;

ANIMAL CELL; ARTICLE; BUNDIBUGYO VIRUS; CONTROLLED STUDY; EBOLAVIRUS; EIDOLON HELVUM; FILOVIRUS; FLYING FOX; HUMAN; HUMAN CELL; LLOVIU VIRUS; MARBURGVIRUS; NONHUMAN; PHYLOGENY; PROTEIN PROCESSING; RESTON VIRUS; SUDAN VIRUS; TAI FOREST VIRUS; VESICULOVIRUS; VIRUS CELL INTERACTION; VIRUS ENTRY; ANIMAL; BAT; FILOVIRIDAE; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; PROTEIN TERTIARY STRUCTURE; SPECIES DIFFERENCE; VIROLOGY;

ANIMALS; CARRIER PROTEINS; CHIROPTERA; FILOVIRIDAE; FURIN; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; SPECIES SPECIFICITY; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84960511083     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149651     Document Type: Article

References (79)

1. Barrette RW, Metwally SA, Rowland JM, Xu L, Zaki SR, Nichol ST, et al. Discovery of swine as a host for the Reston ebolavirus. Science. 2009; 325(5937):204-6. doi: 10.1126/science.1172705 PMID: 19590002.
2. Jayme SI, Field HE, de Jong C, Olival KJ, Marsh G, Tagtag AM, et al. Molecular evidence of Ebola Reston virus infection in Philippine bats. Virology journal. 2015; 12:107. doi: 10.1186/s12985-015-0331-3 PMID: 26184657; PubMed Central PMCID: PMC4504098.
3. Negredo A, Palacios G, Vazquez-Moron S, Gonzalez F, Dopazo H, Molero F, et al. Discovery of an ebolavirus-like filovirus in europe. PLoS pathogens. 2011; 7(10):e1002304. doi: 10.1371/journal.ppat.1002304 PMID: 22039362; PubMed Central PMCID: PMC3197594.
4. Leroy EM, Telfer P, Kumulungui B, Yaba P, Rouquet P, Roques P, et al. A serological survey of Ebola virus infection in central African nonhuman primates. The Journal of infectious diseases. 2004; 190(11):1895-9. doi: 10.1086/425421 PMID: 15529251.
5. Leroy EM, Rouquet P, Formenty P, Souquiere S, Kilbourne A, Froment JM, et al. Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science. 2004; 303(5656):387-90. doi: 10.1126/science.1092528 PMID: 14726594.
6. Nkoghe D, Formenty P, Leroy EM, Nnegue S, Edou SY, Ba JI, et al. [Multiple Ebola virus haemorrhagic fever outbreaks in Gabon, from October 2001 to April 2002]. Bulletin de la Societe de pathologie exotique. 2005; 98 (3):224-9. PMID: 16267965.
7. Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS pathogens. 2012; 8(10):e1002877. doi: 10.1371/journal.ppat.1002877 PMID: 23055920; PubMed Central PMCID: PMC3464226.
8. Amman BR, Jones ME, Sealy TK, Uebelhoer LS, Schuh AJ, Bird BH, et al. Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). Journal of wildlife diseases. 2015; 51 (1):113-24. doi: 10.7589/2014-08-198 PMID: 25375951.
9. He B, Feng Y, Zhang H, Xu L, Yang W, Zhang Y, et al. Filovirus RNA in Fruit Bats, China. Emerging infectious diseases. 2015; 21(9):1675-7. doi: 10.3201/eid2109.150260 PMID: 26291173; PubMed Central PMCID: PMC4550138.
10. Jones ME, Schuh AJ, Amman BR, Sealy TK, Zaki SR, Nichol ST, et al. Experimental Inoculation of Egyptian Rousette Bats (Rousettus aegyptiacus) with Viruses of the Ebolavirus and Marburgvirus Genera. Viruses. 2015; 7(7):3420-42. doi: 10.3390/v7072779 PMID: 26120867; PubMed Central PMCID: PMC4517108.
11. Paweska JT, Jansen van Vuren P, Masumu J, Leman PA, Grobbelaar AA, Birkhead M, et al. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus. PloS one. 2012; 7(9):e45479. doi: 10.1371/journal.pone.0045479 PMID: 23029039; PubMed Central PMCID: PMC3444458.
12. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, Kemp A, et al. Studies of reservoir hosts for Marburg virus. Emerging infectious diseases. 2007; 13(12):1847-51. doi: 10.3201/eid1312.071115 PMID: 18258034; PubMed Central PMCID: PMC2876776.
13. Taniguchi S, Watanabe S, Masangkay JS, Omatsu T, Ikegami T, Alviola P, et al. Reston Ebolavirus antibodies in bats, the Philippines. Emerging infectious diseases. 2011; 17(8):1559-60. doi: 10.3201/eid1708. 101693 PMID: 21801651; PubMed Central PMCID: PMC3381561.
14. Towner JS, Amman BR, Sealy TK, Carroll SA, Comer JA, Kemp A, et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS pathogens. 2009; 5(7):e1000536. doi: 10.1371/journal.ppat. 1000536 PMID: 19649327; PubMed Central PMCID: PMC2713404.
15. Towner JS, Pourrut X, Albarino CG, Nkogue CN, Bird BH, Grard G, et al. Marburg virus infection detected in a common African bat. PloS one. 2007; 2(8):e764. doi: 10.1371/journal.pone.0000764 PMID: 17712412; PubMed Central PMCID: PMC1942080.
16. Yuan J, Zhang Y, Li J, Zhang Y, Wang LF, Shi Z. Serological evidence of ebolavirus infection in bats, China. Virology journal. 2012; 9:236. doi: 10.1186/1743-422X-9-236 PMID: 23062147; PubMed Central PMCID: PMC3492202.
17. Moratelli R, Calisher CH. Bats and zoonotic viruses: can we confidently link bats with emerging deadly viruses? Memorias do Instituto Oswaldo Cruz. 2015; 110(1):1-22. doi: 10.1590/0074-02760150048 PMID: 25742261; PubMed Central PMCID: PMC4371215.
18. Smith I, Wang LF. Bats and their virome: an important source of emerging viruses capable of infecting humans. Current opinion in virology. 2013; 3(1):84-91. doi: 10.1016/j.coviro.2012.11.006 PMID: 23265969.
19. Hofmann-Winkler H, Kaup F, Pohlmann S. Host cell factors in filovirus entry: novel players, new insights. Viruses. 2012; 4(12):3336-62. PMID: 23342362; PubMed Central PMCID: PMC3528269.
20. Groseth A, Marzi A, Hoenen T, Herwig A, Gardner D, Becker S, et al. The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS pathogens. 2012; 8(8):e1002847. doi: 10.1371/journal.ppat. 1002847 PMID: 22876185; PubMed Central PMCID: PMC3410889.
21. Takada A, Kawaoka Y. The pathogenesis of Ebola hemorrhagic fever. Trends in microbiology. 2001; 9 (10):506-11. PMID: 11597453.
22. Volchkov VE, Feldmann H, Volchkova VA, Klenk HD. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proceedings of the National Academy of Sciences of the United States of America. 1998; 95(10):5762-7. PMID: 9576958; PubMed Central PMCID: PMC20453.
23. Neumann G, Geisbert TW, Ebihara H, Geisbert JB, Daddario-Di Caprio KM, Feldmann H, et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. Journal of virology. 2007; 81(6):2995-8. doi: 10.1128/JVI.02486-06 PMID: 17229700; PubMed Central PMCID: PMC1866002.
24. Neumann G, Feldmann H, Watanabe S, Lukashevich I, Kawaoka Y. Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture. Journal of virology. 2002; 76(1):406-10. PMID: 11739705; PubMed Central PMCID: PMC135697.
25. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. Journal of virology. 2002; 76(13):6841-4. PMID: 12050398; PubMed Central PMCID: PMC136246.
26. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, et al. DC-SIGN and DCSIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology. 2003; 305(1):115-23. PMID: 12504546.
27. Marzi A, Moller P, Hanna SL, Harrer T, Eisemann J, Steinkasserer A, et al. Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. The Journal of infectious diseases. 2007; 196 Suppl 2:S237-46. doi: 10.1086/520607 PMID: 17940955.
28. Kondratowicz AS, Lennemann NJ, Sinn PL, Davey RA, Hunt CL, Moller-Tank S, et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(20):8426-31. doi: 10.1073/pnas.1019030108 PMID: 21536871; PubMed Central PMCID: PMC3100998.
29. Hunt CL, Kolokoltsov AA, Davey RA, Maury W. The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. Journal of virology. 2011; 85(1):334-47. doi: 10.1128/JVI.01278-09 PMID: 21047970; PubMed Central PMCID: PMC3014168.
30. Schornberg KL, Shoemaker CJ, Dube D, Abshire MY, Delos SE, Bouton AH, et al. Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106(19):8003-8. doi: 10.1073/pnas.0807578106 PMID: 19416892; PubMed Central PMCID: PMC2683081.
31. Shimojima M, Takada A, Ebihara H, Neumann G, Fujioka K, Irimura T, et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. Journal of virology. 2006; 80(20):10109-16. doi: 10.1128/JVI.01157-06 PMID: 17005688; PubMed Central PMCID: PMC1617303.
32. Sakurai Y, Kolokoltsov AA, Chen CC, Tidwell MW, Bauta WE, Klugbauer N, et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015; 347 (6225):995-8. doi: 10.1126/science.1258758 PMID: 25722412; PubMed Central PMCID: PMC4550587.
33. Shah PP, Wang T, Kaletsky RL, Myers MC, Purvis JE, Jing H, et al. A small-molecule oxocarbazate inhibitor of human cathepsin L blocks severe acute respiratory syndrome and ebola pseudotype virus infection into human embryonic kidney 293T cells. Molecular pharmacology. 2010; 78(2):319-24. doi: 10.1124/mol.110.064261 PMID: 20466822; PubMed Central PMCID: PMC2917856.
34. Schornberg K, Matsuyama S, Kabsch K, Delos S, Bouton A, White J. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. Journal of virology. 2006; 80(8):4174-8. doi: 10.1128/JVI.80.8. 4174-4178.2006 PMID: 16571833; PubMed Central PMCID: PMC1440424.
35. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science. 2005; 308(5728):1643-5. doi: 10.1126/science.1110656 PMID: 15831716.
36. Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature. 2011; 477(7364):344-8. doi: 10.1038/nature10380 PMID: 21866101
37. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 2011; 477(7364):340-3. doi: 10.1038/nature10348 PMID: 21866103; PubMed Central PMCID: PMC3175325.
38. Ng M, Ndungo E, Jangra RK, Cai Y, Postnikova E, Radoshitzky SR, et al. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology. 2014; 468-470:637-46. doi: 10.1016/j.virol.2014.08.019 PMID: 25310500; PubMed Central PMCID: PMC4252868.
39. Hoffmann M, Muller MA, Drexler JF, Glende J, Erdt M, Gutzkow T, et al. Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses. PloS one. 2013; 8(8):e72942. doi: 10.1371/journal.pone.0072942 PMID: 24023659; PubMed Central PMCID: PMC3758312.
40. Muller MA, Raj VS, Muth D, Meyer B, Kallies S, Smits SL, et al. Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. mBio. 2012; 3 (6). doi: 10.1128/mBio.00515-12 PMID: 23232719; PubMed Central PMCID: PMC3520110.
41. Biesold SE, Ritz D, Gloza-Rausch F, Wollny R, Drexler JF, Corman VM, et al. Type I interferon reaction to viral infection in interferon-competent, immortalized cell lines from the African fruit bat Eidolon helvum. PloS one. 2011; 6(11):e28131. doi: 10.1371/journal.pone.0028131 PMID: 22140523; PubMed Central PMCID: PMC3227611.
42. Kuhl A, Hoffmann M, Muller MA, Munster VJ, Gnirss K, Kiene M, et al. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. The Journal of infectious diseases. 2011; 204 Suppl 3: S840-9. doi: 10.1093/infdis/jir306 PMID: 21987760; PubMed Central PMCID: PMC3189982.
43. Kruger N, Hoffmann M, Drexler JF, Muller MA, Corman VM, Drosten C, et al. Attachment protein G of an African bat henipavirus is differentially restricted in chiropteran and nonchiropteran cells. Journal of virology. 2014; 88(20):11973-80. doi: 10.1128/JVI.01561-14 PMID: 25100832; PubMed Central PMCID: PMC4178722.
44. Simmons G, Wool-Lewis RJ, Baribaud F, Netter RC, Bates P. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. Journal of virology. 2002; 76(5):2518-28. PMID: 11836430; PubMed Central PMCID: PMC153797.
45. Marzi A, Akhavan A, Simmons G, Gramberg T, Hofmann H, Bates P, et al. The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. Journal of virology. 2006; 80(13):6305-17. doi: 10.1128/JVI.02545-05 PMID: 16775318; PubMed Central PMCID: PMC1488929.
46. Wrensch F, Karsten CB, Gnirss K, Hoffmann M, Lu K, Takada A, et al. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses. The Journal of infectious diseases. 2015; 212 Suppl 2:S210-8. doi: 10.1093/infdis/jiv255 PMID: 26034199; PubMed Central PMCID: PMC4564551.
47. Hofmann-Winkler H, Gnirss K, Wrensch F, Pohlmann S. Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976. The Journal of infectious diseases. 2015; 212 Suppl 2: S172-80. doi: 10.1093/infdis/jiv101 PMID: 25840443; PubMed Central PMCID: PMC4564534.
48. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991; 108(2):193-9. PMID: 1660837.
49. Marzi A, Gramberg T, Simmons G, Moller P, Rennekamp AJ, Krumbiegel M, et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. Journal of virology. 2004; 78(21):12090-5. doi: 10.1128/JVI.78.21.12090-12095.2004 PMID: 15479853; PubMed Central PMCID: PMC523257.
50. Maruyama J, Miyamoto H, Kajihara M, Ogawa H, Maeda K, Sakoda Y, et al. Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus. Journal of virology. 2014; 88(1):99-109. doi: 10.1128/JVI.02265-13 PMID: 24131711; PubMed Central PMCID: PMC3911722.
51. Zimmer G, Locher S, Berger Rentsch M, Halbherr SJ. Pseudotyping of vesicular stomatitis virus with the envelope glycoproteins of highly pathogenic avian influenza viruses. The Journal of general virology. 2014; 95(Pt 8):1634-9. doi: 10.1099/vir.0.065201-0 PMID: 24814925.
52. Berger Rentsch M, Zimmer G. A vesicular stomatitis virus replicon-based bioassay for the rapid and sensitive determination of multi-species type I interferon. PloS one. 2011; 6(10):e25858. doi: 10.1371/journal.pone. 0025858 PMID: 21998709; PubMed Central PMCID: PMC3187809.
53. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Molecular biology and evolution. 2013; 30(12):2725-9. doi: 10.1093/molbev/mst197 PMID: 24132122; PubMed Central PMCID: PMC3840312.
54. Hanika A, Larisch B, Steinmann E, Schwegmann-Wessels C, Herrler G, Zimmer G. Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes. The Journal of general virology. 2005; 86(Pt 5):1455-65. doi: 10.1099/vir.0.80788-0 PMID: 15831958.
55. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, et al. Fruit bats as reservoirs of Ebola virus. Nature. 2005; 438(7068):575-6. doi: 10.1038/438575a PMID: 16319873.
56. Redlist I. The IUCN Red List of Threatened Species www.iucnredlist.org2015 [updated 03/2015; cited 2015 27.10.2015]. Available: www.iucnredlist.org.
57. Wool-Lewis RJ, Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. Journal of virology. 1999; 73(2):1419-26. PMID: 9882347; PubMed Central PMCID: PMC103966.
58. Medina MF, Kobinger GP, Rux J, Gasmi M, Looney DJ, Bates P, et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Molecular therapy: the journal of the American Society of Gene Therapy. 2003; 8(5):777-89. PMID: 14599811.
59. Jeffers SA, Sanders DA, Sanchez A. Covalent modifications of the ebola virus glycoprotein. Journal of virology. 2002; 76(24):12463-72. PMID: 12438572; PubMed Central PMCID: PMC136726.
60. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. Journal of virology. 2004; 78(6):2943-7. PMID: 14990712; PubMed Central PMCID: PMC353724.
61. Lu F, Liang Q, Abi-Mosleh L, Das A, De Brabander JK, Goldstein JL, et al. Identification of NPC1 as the target of U18666A, an inhibitor of lysosomal cholesterol export and Ebola infection. eLife. 2015; 4. doi: 10.7554/eLife.12177 PMID: 26646182; PubMed Central PMCID: PMC4718804.
62. Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, et al. Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. PloS one. 2013; 8(4):e60838. doi: 10.1371/journal.pone.0060838 PMID: 23573288; PubMed Central PMCID: PMC3614905.
63. Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. Journal of virology. 1998; 72(4):3155-60. PMID: 9525641; PubMed Central PMCID: PMC109772.
64. Chazal N, Singer G, Aiken C, Hammarskjold ML, Rekosh D. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. Journal of virology. 2001; 75(8):4014-8. doi: 10.1128/JVI.75.8.4014-4018.2001 PMID: 11264394; PubMed Central PMCID: PMC114896.
65. Gnirss K, Kuhl A, Karsten C, Glowacka I, Bertram S, Kaup F, et al. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology. 2012; 424(1):3-10. doi: 10.1016/j.virol.2011.11.031 PMID: 22222211.
66. Hosoya M, Matsuyama S, Baba M, Suzuki H, Shigeta S. Effects of protease inhibitors on replication of various myxoviruses. Antimicrobial agents and chemotherapy. 1992; 36(7):1432-6. PMID: 1510439; PubMed Central PMCID: PMC191599.
67. Shirato K, Kawase M, Matsuyama S. Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. Journal of virology. 2013; 87(23):12552-61. doi: 10.1128/JVI. 01890-13 PMID: 24027332; PubMed Central PMCID: PMC3838146.
68. Zhou Y, Vedantham P, Lu K, Agudelo J, Carrion R Jr, Nunneley JW, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral research. 2015; 116:76-84. doi: 10.1016/j.antiviral.2015.01.011 PMID: 25666761.
69. Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, et al. Multiple cationic amphiphiles induce a Niemann-Pick C phenotype and inhibit Ebola virus entry and infection. PloS one. 2013; 8(2): e56265. doi: 10.1371/journal.pone.0056265 PMID: 23441171; PubMed Central PMCID: PMC3575416.
70. Yao Y, Ghosh K, Epand RF, Epand RM, Ghosh HP. Membrane fusion activity of vesicular stomatitis virus glycoprotein G is induced by low pH but not by heat or denaturant. Virology. 2003; 310(2):319-32. PMID: 12781719.
71. Diederich S, Thiel L, Maisner A. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology. 2008; 375(2):391-400. doi: 10.1016/j.virol.2008.02.019 PMID: 18342904.
72. Biek R, Walsh PD, Leroy EM, Real LA. Recent common ancestry of Ebola Zaire virus found in a bat reservoir. PLoS pathogens. 2006; 2(10):e90. doi: 10.1371/journal.ppat.0020090 PMID: 17069458; PubMed Central PMCID: PMC1626099.
73. Ng M, Ndungo E, Kaczmarek ME, Herbert AS, Binger T, Kuehne AI, et al. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. eLife. 2015; 4. doi: 10.7554/eLife.11785 PMID: 26698106; PubMed Central PMCID: PMC4709267.
74. Marzi A, Feldmann F, Hanley PW, Scott DP, Gunther S, Feldmann H. Delayed Disease Progression in Cynomolgus Macaques Infected with Ebola Virus Makona Strain. Emerging infectious diseases. 2015; 21 (10):1777-83. doi: 10.3201/eid2110.150259 PMID: 26402165; PubMed Central PMCID: PMC4593438.
75. Dahlmann F, Biedenkopf N, Babler A, Jahnen-Dechent W, Karsten CB, Gnirss K, et al. Analysis of Ebola Virus Entry Into Macrophages. The Journal of infectious diseases. 2015; 212 Suppl 2:S247-57. doi: 10.1093/infdis/jiv140 PMID: 25877552; PubMed Central PMCID: PMC4564540.
76. Bottcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, Matrosovich M. Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. Journal of virology. 2006; 80 (19):9896-8. doi: 10.1128/JVI.01118-06 PMID: 16973594; PubMed Central PMCID: PMC1617224.
77. Chaipan C, Kobasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, et al. Proteolytic activation of the 1918 influenza virus hemagglutinin. Journal of virology. 2009; 83(7):3200-11. doi: 10.1128/JVI.02205-08 PMID: 19158246; PubMed Central PMCID: PMC2655587.
78. Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. Journal of virology. 2010; 84(24):12658-64. doi: 10.1128/JVI.01542-10 PMID: 20926566; PubMed Central PMCID: PMC3004351.
79. Gierer S, Bertram S, Kaup F, Wrensch F, Heurich A, Kramer-Kuhl A, et al. The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. Journal of virology. 2013; 87(10):5502-11. doi: 10.1128/JVI.00128-13 PMID: 23468491; PubMed Central PMCID: PMC3648152.